title: Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes.
abstract: Association of gene alterations and prognosis has not fully been elucidated in hepatocellular carcinoma (HCC). To clarify the relationship between p53 and hMSH2 mutations and prognosis, we analysed these mutations in 83 HCC cases and assessed their association with various clinicopathological factors. The 3-year disease-free survival (DFS) or overall survival (OS) rates in HCC patients with p53 mutation and p53 wild/hMSH2 mutation significantly decreased compared with those without these mutations (14.3% and 37.5% versus 67.5% for DFS; 35.7% and 50.0% versus 96.4% for OS, respectively). In the multivariate analysis, categories by p53 and hMSH2 mutation status, and liver cirrhosis demonstrated statistical significances for DFS and OS. Moreover, the frequency of patients with p53 and/or hMSH2 mutations in intrahepatic metastasis (75.0%) was significantly higher than that in multicentric occurrence (14.3%). Thus, p53 and hMSH2 mutations will be useful for identifying subsets of HCC patients with poor prognosis.
authors.affiliation: Department of Surgery, Akane Foundation Tsuchiya General Hospital, 3-30 Nakajima-chou, Naka-ku, Hiroshima 730-8655, Japan. yano3masa@ybb.ne.jp
authors.forename: Masatsugu
authors.initials: M
authors.lastname: Yano
authors.forename: Kiyohiro
authors.initials: K
authors.lastname: Hamatani
authors.forename: Hidetaka
authors.initials: H
authors.lastname: Eguchi
authors.forename: Yuko
authors.initials: Y
authors.lastname: Hirai
authors.forename: Donald G
authors.initials: DG
authors.lastname: MacPhee
authors.forename: Keizo
authors.initials: K
authors.lastname: Sugino
authors.forename: Kiyohiko
authors.initials: K
authors.lastname: Dohi
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Itamoto
authors.forename: Toshimasa
authors.initials: T
authors.lastname: Asahara
mesh_terms: D000368:Aged; D000704:Analysis of Variance; D006528:Carcinoma, Hepatocellular / Q000235:genetics* / Q000401:mortality; D018572:Disease-Free Survival; D005091:Exons / Q000235:genetics; D005260:Female; D016158:Genes, p53; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D051718:MutS Homolog 2 Protein / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D009364:Neoplasm Recurrence, Local / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis; D018807:Polymorphism, Single-Stranded Conformational; D011379:Prognosis
chemical_list: C497172:MSH2 protein, human; D051718:MutS Homolog 2 Protein